Explore Key Topics in Nephrology
Through lectures, case discussions and board preparation sessions, Intensive Review of Nephrology provides a highly focused look at all major fields of nephrology. Harvard Medical School clinical faculty help you stay current and prepare for exams as they discuss:
- The latest options for diagnosis: what to choose, when, and why
- Current evidence-based treatment and care management strategies to optimize patient outcomes
- Improved approaches to common and complex clinical challenges
- Navigating clinical controversies
- Avoiding medical mistakes
- And more…
Expand Your Skills
Available online or via USB, Intensive Review of Nephrology provides a maximum of 44.75 AMA PRA Category 1 Credits ™ and 44.75 ABIM MOC points and access to unbiased, evidence-based content and case-based reviews so you can prep for exams while learning to incorporate the latest guidelines into your daily practice.
Date of Original Release: October 15, 2020
Termination Date: January 31, 2023
Topics/speakers:
Glomerulonephritis
- Renal Physiology for the Boards – Melanie P. Hoenig, MD
- Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD
- Renal Pathology in 2020: Part 1 – Helmut G. Rennke, MD
- Renal Pathology in 2020: Part 2 – Astrid Weins, MD, PhD
- Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD
- IgA Nephropathy – Gerald B. Appel, MD
- Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
- ANCA Vasculitis – John L. Niles, MD
- Update on Lupus Nephritis – Gerald B. Appel, MD
- Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
- Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
- Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD
- Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
- Must-Know Board Zebra – Emily Robinson, MD, MPH
- Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
- Nephrology Board Review Practice 2 – Mallika Mendu, MD
Electrolytes and Acid Base
- Workshop: Hyponatremia and Hypernatremia – David B. Mount, MD
- Hypokalemia and Hyperkalemia – David B. Mount, MD
- Acid-Base Part I – Acidosis – Alan S.L. Yu, MB, BChir
- Acid-Base Part II – Alkalosis – Alan S.L. Yu, MB, BChir
- COVID-19 and Kidney Disease – Daniel Batlle, MD
- Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
- Update on Polycystic Kidney Disease – Cristian Riella, MD
- Pediatric Nephrology – Michael J.G. Somers, MD
- Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH
- Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 1 – Alan S.L. Yu, MB, BChir
- Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 2 – Alan S.L. Yu, MB, BChir
- Chronic Kidney Disease in the Community: Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP
Transplantation
- Why Do We Reject a Transplant? – Jamil R. Azzi, MD
- Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
- Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
- Early Post-Transplant Management – Anil K. Chandraker, MD
- Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD
- Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD
- Infections in Transplant Recipients – Sarah P. Hammond, MD
- COVID-19 and Transplant Patients – Enver Akalin, MD, FAST, FASN
- Renal Transplant Recipient Medical Evaluation – Jamil R. Azzi, MD
- Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS
- Donor Evaluation – Kassem Safa, MD
- Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
- Thrombotic Microangiopathies – Jean M. Francis, MD
- Geriatric Nephrology – Ernest I. Mandel, MD
- Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD, and Edgar L. Milford, MD
- Transplant Board Review – Leonardo V. Riella, MD, PhD
CKD and General Nephrology
- Update on Renovascular Disease – Joseph M. Garasic, MD
- Management of Hypertension after SPRINT – Richard J. Glassock, MD
- Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
- Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
- Liver and the Kidney – Andrew S. Allegretti, MD, MSc
Acute Kidney Injury
- Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
- Acute Kidney Injury Syndromes – Alice Sheridan, MD
- ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
- COVID-19 in the ICU – Jeremy B. Richards, MD
- Cancer and Acute Kidney Injury – Albert Q. Lam, MD
- Paraprotein Induced Kidney Injury – Albert Q. Lam, MD
- FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD
- Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH
- APOL1 and Kidney Disease – Martin R. Pollak, MD
Dialysis
- Dialysis Dosing – J. Kevin Tucker, MD
- Mineral and Bone Disease – David Bushinsky, MD
- Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
- Pearls in Mineral and Bone Disease – David Bushinsky, MD
- Chronic Kidney Disease Epidemiology: A 2019 Update – Gearoid M. McMahon, MB BCh
- Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
- Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
- COVID-19 and Patients on Dialysis – Giuliano Brunori, MD
- Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
- Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD
Reviews
There are no reviews yet.